Ideaya Biosciences
IDYA35.7101.90% ( -0.690 )
Ideaya Biosciences (IDYA)
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in...
- Open
- 36.370
- High
- 36.370
- Low
- 35.378
- Prev. Close
- 36.400
- Volume
- 102.40K
- Turnover
- 3.67M
- Avg Price
- 35.845
- Bid/Ask Ratio
- --
- Amplitude
- 2.73%
- 52wk High
- 40.580
- Volume Ratio
- 0.40
- Turnover Ratio
- 0.11%
Ideaya Biosciences Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$53.5449.17%
Forecast & RatingStrong buy
15analysts
- Strong buy73.33%
- Buy20.00%
- Hold6.67%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 5 hours ago
IDEAYA Biosciences grants 260,200 inducement stock options at $36.4 per share
- StockTitan · 13 hours ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | IDYA Stock News
- Market Beat · 2 days ago, 04:53 AM
IDEAYA Biosciences, Inc. $IDYA Shares Sold by Redmile Group LLC
- Tip Ranks · Jul 27 at 06:55 AM
IDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained
- StockTitan · Jul 26 at 09:00 PM
IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers | IDYA Stock News
- PUBT · Jul 17 at 08:00 AM
IDEAYA shares ESMO 2026 data updates for darovasertib trials in uveal melanoma
